Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Bei jing, China Clinical Trials

A listing of Bei jing, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (4) clinical trials

11C-PIB PET/CT in Patients With Parkinson's Disease and Parkinsonian Dementia Syndromes

Study design: Multi-center, Five-arm Subjects Patients with PD without dementia; Patients with PD with mild cognitive impairment (MCI); Patients with PD with dementia; Patients with a dementia with Lewy bodies(DLB); Healthy person Sample size: 200, including a PD without dementia group of 75 patients, a PD with MCI group of ...

Phase

0.0 miles

Learn More »

New Strategy of Improving Treatment Outcome and Larynx-preservation Rate in Locally Advanced Hypopharyngeal Carcinoma

Eligliblity patient were assign to induction chemotherapy plus concurrent chemotherapy group (IC +CCRT group, Arm A)and concurrent chemoradiotherapy group(CCRT group, Arm B). For patients in ArmA, treatment response were evaluated after 2cycles, if the respnse reached PR/CR, patients received concurrent chemoradiotherapy, otherwise, paitents will recived surgery and RT/CCRT after surgery. ...

Phase

3.37 miles

Learn More »

A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer Subjects With the Overexpression of HER2

This study will evaluate the efficacy and safety of intravenous RC48-ADC in local advanced or metastatic gastric patients with the overexpression of HER2.

Phase

6.12 miles

Learn More »

CART-123 FOR Relapsed/Refractory Acute Myelocytic Leukemia AML

The relapsed/refractory AML patients will receive FC (F,FludarabineCCyclophosphamide) chemotherapy followed by infusion of allogenic or autologous CD123-Targeted CAR-T cells.No graft-versus-host disease (GVHD) prevention will be conducted before or after infusion. Dose-limiting toxicity,incidence of adverse events and disease response will be detected post-infusion.

Phase

7.74 miles

Learn More »